Squamous Cell Carcinoma of the Nasopharynx
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Nasopharynx.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 trial evaluating erlotinib hydrochloride with radiation therapy in various Stage III-IV squamous cell carcinomas of the head and nec…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride for stage IV or recurrent nasopharyngeal carcinoma has completed. Results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 trial update on intratumoral PV701 for patients with advanced or unresectable recurrent squamous cell carcinoma of the head and neck…
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating bortezomib with or without irinotecan in locally recurrent or metastatic squamous cell carcinoma of the head and ne…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.